![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Okami’s Vascular Occlusion System
FDA Clears Okami’s Vascular Occlusion System
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
November 4, 2019
The FDA granted Okami Medical 510(k) clearance for its Lobo vascular occlusion system, a device used in the occlusion of peripheral blood vessels.
The low-profile braided occluder is a minimally invasive device for rapid and focal occlusion of a wide range of arterial targets.
The system is compatible with microcatheters, allowing it to navigate the peripheral vasculature. It self-expands upon deployment and can conform to multiple targets, including curved vessels.
Upcoming Events
-
21Oct